QORIN SEPSISI VA ASORATLI NOZOKOMIAL PNEVMONIYASI BOR BEMORLARDA KLEBSIELLA PNEUMONIAE SHTAMMLARINING KARBAPENEMLARGA REZISTENTLIK PROFILI.

Authors

  • Saydakbarov Asilbek Jumaboy o‘g‘li Central Asian Medical University CAMU ordinator Reanimatsiya va Anistezialogiya yo‘nalishi E.mail doctorbek3000@gmail.com Tel.91 674-41-44

Keywords:

Kalit so‘zlar: Klebsiella pneumoniae, qorin sepsisi, nozokomial pnevmoniya, karbapenem rezistentligi, karbapenemazalar, intensiv terapiya, antibiotik rezistentlik profili.

Abstract

Annotatsiya: Ushbu ilmiy tezisda qorin sepsisi va asoratli nozokomial pnevmoniya bilan og‘rigan bemorlardan ajratib olingan Klebsiella pneumoniae shtammlarining karbapenem guruhiga kiruvchi antibiotiklarga rezistentlik profili tahlil qilingan. So‘nggi yillarda ko‘p dori-darmonlarga chidamli (MDR) va ekstremal chidamli (XDR) shtammlarning shifoxona ichki infeksiyalarida, ayniqsa, intensiv terapiya bo‘limlarida (ITB) ko‘payishi davolash samaradorligini keskin pasaytirmoqda. Tadqiqot davomida bemorlardan olingan klinik namunalar asosida mikrobiologik va molekulyar-genetik tahlillar o‘tkazildi. Natijalar K. pneumoniae shtammlarining imipenem va meropenemga bo‘lgan yuqori chidamliligini, shuningdek, ularning tarkibida karbapenemaza genlarining (ayniqsa, $bla_{NDM}$ va $bla_{OXA-48}$) mavjudligini ko‘rsatdi. Olingan ma’lumotlar shifoxonalarda empirik antibakterial terapiyani optimallashtirish va infeksion nazoratni kuchaytirish zarurligini asoslaydi.

References

1.Aliev, S. A., & Mamedov, K. N. (2022). Nosocomial abdominal sepsis: pathogenesis, diagnostics and treatment tactics. Journal of Surgical Infection, 24(2), 112–118.

2.Podschun, R., & Ullmann, U. (1998). Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clinical Microbiology Reviews, 11(4), 589–603.

3.Nordmann, P., Naas, T., & Poirel, L. (2011). Global spread of Carbapenemase-producing Enterobacteriaceae. Emerging Infectious Diseases, 17(10), 1791–1798.

4.Queenan, A. M., & Bush, K. (2007). Carbapenemases: the versatile beta-lactamases. Clinical Microbiology Reviews, 20(3), 440–458.

5.Torres, A., Niederman, M. S., & Chastre, J. (2017). International European Latin American Guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. European Respiratory Journal, 50(3), 1700–1745.

6.EUCAST. (2024). European Committee on Antimicrobial Susceptibility Testing. Guidelines for detection of resistance mechanisms and specific resistances. EUCAST Clinical Documents, v.14.0, 45–52.

7.Pierce, V. M., Simner, P. J., & Lonsway, D. R. (2017). Modified Carbapenem Inactivation Method for detection of Carbapenemase production among Enterobacteriaceae. Journal of Clinical Microbiology, 55(8), 2421–2433.

8.Dallenne, C., Da Costa, A., & Decré, D. (2010). Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy, 65(3), 490–495.

9.Navon-Venezia, S., Kondratyeva, K., & Carattoli, A. (2017). Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiology Reviews, 41(3), 252–275.

10.Tischendorf, J., de Avila, R. A., & Safdar, N. (2016). Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a systematic review and meta-analysis. American Journal of Infection Control, 44(5), 509–517.

11.Azizov, Y. A., & Akhmedov, R. S. (2023). Molecular epidemiology of carbapenem-resistant Enterobacteriaceae in Central Asia. Central Asian Journal of Medicine, 12(1), 78–85.

12.Bonomo, R. A., Burd, E. M., & Conly, J. (2018). Carbapenemase-producing organisms: a global scourge. Clinical Infectious Diseases, 66(8), 1290–1297.

Downloads

Published

2026-06-20

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.